Skip Navigation


NDT Advance Access originally published online on November 14, 2006
Nephrology Dialysis Transplantation 2007 22(2):424-431; doi:10.1093/ndt/gfl588
This Article
Right arrow Abstract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
22/2/424    most recent
gfl588v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Kamel, K. S.
Right arrow Articles by Halperin, M. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kamel, K. S.
Right arrow Articles by Halperin, M. L.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2006]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Studies to identify the basis for an alkaline urine pH in patients with calcium hydrogen phosphate kidney stones

Kamel S. Kamel, Mohammad A. Shafiee, Surinder Cheema-Dhadli and Mitchell L. Halperin

Renal Division, St Michael's Hospital, University of Toronto, Toronto, Ontario, Canada

Correspondence and offprint requests to: Kamel S. Kamel, MD, University of Toronto, St. Michael's Hospital, Division of Nephrology, 61 Queen Street, Toronto, Ontario M5B 1A6, Canada. Email: kamel.kamel{at}utoronto.ca



   Abstract
 Top
 Abstract
 Introduction
 Subjects and methods
 Results
 Discussion
 Conclusions
 Appendix
 Acknowledgements
 References
 
Background. Patients with CaHPO4 kidney stones belong to a diagnostic category that has a high urine pH as its common feature. Our objective was to provide a new clinical approach to examine the basis for this high pH.

Methods. The study group consisted of 26 CaHPO4 stone formers and 28 normal volunteers. Urine was collected q2h plus an overnight sample to identify patients with a urine pH > 6.5 for 12/24 h. Urine ammonium (UNH4), sulphate (USO4) and citrate were measured and diet net alkali was calculated.

Results. Of the 26 patients, 13 had persistently alkaline urine. In 7/13, UNH4 (68 ± 13 mEq/day) and USO4 (57 ± 7 mEq/day) were both high. In 6/13 patients, UNH4 was the usual 31 ± 3 mEq/day; in 4/6, UNH4/USO4 was 0.9 ± 0.1; the cause of the alkaline urine pH seemed to be a dietary alkali load because the rise in urine pH was episodic and coincided with a high net diet alkali load and peak citrate excretion rates. The remaining two patients had a high UNH4/USO4 (2.2 and 1.6). Citrate excretion was very low in the male, but not in the female patient.

Conclusions. There are heterogeneous causes for a persistently high urine pH. Two of the patients had a possible molecular basis: the lesion could be a low proximal convoluted tubule cell pH in the male and an increased entry of NH3 into the late distal nephron in the female.

Keywords: alkali ingestion; ammonium; citrate; kidney stones; sulphate; urine pH



   Introduction
 Top
 Abstract
 Introduction
 Subjects and methods
 Results
 Discussion
 Conclusions
 Appendix
 Acknowledgements
 References
 
Nephrolithiasis is a common disorder that is associated with significant morbidity and a substantial cost to the health care system. About 15% of kidney stone formers produce stones that are composed predominantly of calcium hydrogen phosphate (CaHPO4) [1]. In a recent study, Evan et al. [2] demonstrated that patients with this type of kidney stone develop progressive parenchymal damage and nephron loss due to plugging of the terminal collecting duct with CaHPO4 crystals. These findings emphasize the importance of understanding the underlying pathophysiology that leads to the precipitation of these crystals so that an effective, individualized therapy could be designed.

CaHPO4 precipitates are formed when the ion product for ionized calcium and divalent phosphate (Formula ) exceeds its solubility product constant (Ksp) and its ability to remain dissolved in a supersaturated solution. Only ~1/6 of the urine phosphate is in the form of Formula when the urine pH is ~6.1 whereas half of the urine phosphate will be in its Formula form at a urine pH of 6.8 (the pK for this buffer system in urine, Table 1) [3]; hence, a urine pH of 6.8 increases the potential risk for precipitation of CaHPO4 by 3-fold. On the other hand, there is little extra risk when the urine pH rises from 7.1 to 7.5.


View this table:
[in this window]
[in a new window]

 
Table 1. Effect of raising the urine pH on the divalent phosphate concentration

 
Patients with CaHPO4 kidney stones belong to a diagnostic category that have a common feature—a high urine pH (1)—rather than representing a specific disease entity. It is important to establish the basis for this high urine pH, to understand why recurrent CaHPO4 kidney stones are formed in an individual patient, because there are many possible explanations for this alkaline urine pH. For example, patients with distal renal tubular acidosis (RTA) caused by a low net distal H+ secretion rate have a high urine pH. Because of acidaemia, they also have a low rate of excretion of citrate and thereby, an increased risk of forming CaHPO4 kidney stones [4]. Since the pathophysiology in this subgroup of patients is well-characterized, these patients were excluded from the present investigation.

The focus of this investigation is on a different subgroup of patients. Although they too have a persistently high urine pH, they are easily distinguished from patients with distal RTA because metabolic acidosis is not present and they do not have a low rate of excretion of Formula [5]. The rate of excretion of Formula should be examined relative to the dietary non-volatile acid load that requires the excretion of Formula (UNH4) for H+ elimination. This is revealed for the most part by the rate of excretion of sulphate anions (Formula ) in the urine (USO4). In control subjects, the UNH4/USO4 is close to 1 in mEq terms [6].

Our results show that in a subgroup of patients, the rate of excretion of Formula was high, but the UNH4/USO4 was close to 1—this indicated that the high medullary interstitial NH3 in these patients was due to a high diet acid load (equation 1). In another subgroup, the rate of excretion of Formula was not high; these patients however, represented two distinct causes based on their UNH4/USO4. In some, the UNH4/USO4 was close to one; hence the alkaline urine pH seemed to be driven by a high episodic dietary alkali intake. Two patients had high UNH4/USO4 (2.2 and 1.6)—their rate of excretion of citrate was markedly different, and this suggested two different possible lesions to explain their persistently alkaline urine pH.

Formula 1(1)



   Subjects and methods
 Top
 Abstract
 Introduction
 Subjects and methods
 Results
 Discussion
 Conclusions
 Appendix
 Acknowledgements
 References
 
The Research Ethics Board at St. Michael's Hospital approved the study protocol; informed consent was obtained from all patients and control subjects.

Control subjects
There were 28 normal volunteers, 14 males and 14 females, mean age 32 ± 3 years, with no history of kidney stones.

Patients
Twenty-six patients with recurrent CaHPO4 stones were studied; >50% of each of their stones consisted of CaHPO4 and Ca3(PO4)2 by X-ray diffraction crystallography.

Procedures
Data were obtained while the patients and the control subjects consumed their usual diet, and did not take medications for at least 1 week. To select patients with persistently high urine pH values, urine was voided voluntarily q2h while awake plus an overnight collection (to permit undisturbed sleep) over the 24-h period [6]. Time and volume of voiding were recorded. Thymol was added to the urine as the preservative. To characterize the pathophysiology of the alkaline urine pH, the rate of excretion of Formula , Formula and citrate was measured in 24-h urine collections and net dietary alkali was calculated as described below. Glomerular filtration rate (GFR) was calculated by endogenous creatinine clearance.

Net diet alkali
The potential alkali load of the diet was calculated as the sum of the excretion of urinary cations (Na+ + K+ + Ca2+ + Mg2+) minus the sum of the excretion of urinary anions (Cl + inorganic phosphate) in mEq terms [6,7]. The excretions of Formula and Formula were not included in this analysis because they represent the daily H2SO4 load and its elimination.

Analytical techniques
Bicarbonate (Formula ), pH, sodium (Na+), potassium (K+), chloride (Cl), phosphate, calcium (Ca2+), magnesium (Mg2+), Formula , Formula , creatinine, urea, osmolality and citrate were measured in plasma and urine as previously described [6].



   Results
 Top
 Abstract
 Introduction
 Subjects and methods
 Results
 Discussion
 Conclusions
 Appendix
 Acknowledgements
 References
 
The urine pH was close to 6.0 in the control subjects throughout the day (Figure 1). In addition, the rates of excretion of Formula (28 ± 2 mEq/day) and Formula (31 ± 3 mEq/day) were very similar while citrate excretion was 9 ± 1 mEq/day (Table 2). The ratio of USO4 to nitrogen (UN) in the urine was 2.2% in mmol terms largely reflecting the proportion of sulphur-containing amino acids in their ingested protein.


Figure 1
View larger version (12K):
[in this window]
[in a new window]
[Download PowerPoint slide]
 
Fig. 1. Diurnal variation in the urine pH in control subjects and the index patients. The solid line connecting the filled black squares depicts the values in the control subjects (mean ± SEM). The dashed line connecting the filled circles depicts the data in the male patient, and the dashed line connecting the open circles depicts the data in the female patient.

 

View this table:
[in this window]
[in a new window]

 
Table 2. 24-h Urine values in control subjects and the two index cases

 
In 13/26 patients, the urine pH was not >6.5 for more than 12/24 h; hence these patients were excluded from further study (Figure 2). Although, this definition is arbitrary, our purpose was to focus on patients with persistently high urine pH values.


Figure 2
View larger version (16K):
[in this window]
[in a new window]
[Download PowerPoint slide]
 
Fig. 2. Clinical approach to examine the basis of an alkaline urine pH. The first step was to select those patients (13/26) who had a persistently high urine pH. The second step was to identify patients (7/13) with a high NH4+ excretion rate (>50 mEq/day). Of the remaining 6/13 patients, four had an UNH4/USO4 that was close to unity, and two patients had markedly higher UNH4/USO4 (values in the rectangles below).

 
To characterize the pathophysiology of the alkaline urine pH, patients were separated into two groups based on the rate of excretion of Formula (Figure 2). Seven patients (7/13) had an Formula excretion rate that was greater than 50 mEq/day (68 ± 13 mEq/day); this high Formula excretion rate was accompanied by a rate of excretion of Formula that was almost 2-fold higher than in the control subjects (57 ± 7 vs 31 ± 3 mEq/day).

In the remaining 6/13 patients, the Formula excretion rate was 31 ± 3 mEq/day. These patients, however, represented two distinct subgroups based on their UNH4/USO4. In 4/6 patients, the UNH4/USO4 was close to unity (0.9 ± 0.1). In the diurnal pattern of their urine pH, there was a period where the urine pH was distinctly higher than other values. In a representative patient, the time when there was a higher net alkali excretion rate (Figure 3A), there was a lower rate of excretion of Formula but not Formula (Figure 3B), and a small rise in the rate of excretion of citrate (Figure 3C). This pattern suggests that the basis for the high urine pH might have been a high intake of alkali. The other two patients had very high UNH4/USO4 ratios (1.6 and 2.2). The first patient, a 40-year-old male, passed his first stone at age 10 and the second patient, a 17-year-old female, passed her first stone at age 7. Both patients had urine collections on two occasions that were separated by a period of more than 4 weeks, while consuming their usual diet and taking no medications. While the findings in each patient were similar in both collections, the data shown in Table 2 are from a single 24-h collection in each patient that was selected because the urine flow rate and the ratio of USO4/UN were similar to control subjects. This later ratio was used to ensure that the rate of excretion of Formula reflects the diet acid load from metabolism of sulphur-containing amino acids. The endogenous creatinine clearance was 120 l/day in the male patient and 123 l/day in the female patient.


Figure 3
View larger version (13K):
[in this window]
[in a new window]
[Download PowerPoint slide]
 
Fig. 3. A representative patient with a diet-driven high urine pH. (A) The rate of excretion of alkali in µEq/min, (B) the Figure 3 (filled squares, solid line) and Figure 3 (open squares, dashed line) excretion rates in µEq/min and (C) the urine pH (filled squares, solid line) and the rate of excretion of citrate in µEq/min (open squares, dashed line). When the alkali load was highest, the rate of excretion of Figure 3 was at its nadir. When the alkali load was highest, the urine pH and the excretion of citrate were close to their peak values.

 
The pattern of the urine pH throughout the 24-h cycle in the control subjects and these two patients is shown in Figure 1. The control group had urine pH values that were consistently close to 6.0. In contrast, the two patients had substantially higher urine pH values for the bulk of the 24-h period; the urine pH values were higher in the male patient.

The next factor evaluated was the rate of excretion of Formula and Formula and its variation in the 24-h period. In the male patient, the rate of excretion of Formula was greater than the rate of excretion of Formula throughout the day (Figure 4). It is noteworthy that this was achieved with a urine pH that was ~7.0. In the female patient, there was an 8-h period where the rates of excretion of Formula and Formula were similar, and a 16-h period where the rate of excretion of Formula was considerably greater than that of Formula . Hence, it is possible that there are different mechanisms operating in the two patients.


Figure 4
View larger version (17K):
[in this window]
[in a new window]
[Download PowerPoint slide]
 
Fig. 4. Diurnal excretion of Figure 4 and Figure 4 in the index patients. The excretion rates are plotted in µEq/min for Figure 4 (filled squares connected by the solid line) and for Figure 4 (open squares connected by the dashed line). (A) Data from the male patient and (B) data from the female patient.

 
The final factor evaluated was the rate of excretion of citrate and its variation in the 24-h period. In the male patient, the rate of excretion of citrate was strikingly low throughout the day (Figure 5). This markedly low rate of excretion of citrate was not due to a reduced dietary intake of alkali, as his calculated dietary net alkali load was high (Table 2). In contrast, the rate of excretion of citrate was similar to that in control subjects in the female patient (Figure 5).


Figure 5
View larger version (12K):
[in this window]
[in a new window]
[Download PowerPoint slide]
 
Fig. 5. Diurnal variation in the excretion of citrate in control subjects and in the index patients. The dashed line connecting the open squares depicts the values in the control subjects (mean ± SEM). The solid line connecting the filled squares depicts the data in the male patient and the solid line connecting the open circles depicts the data in the female patient. Only the male patient had a persistent and very low rate of excretion of citrate.

 


   Discussion
 Top
 Abstract
 Introduction
 Subjects and methods
 Results
 Discussion
 Conclusions
 Appendix
 Acknowledgements
 References
 
The purpose of this study was to examine the pathophysiology of the alkaline urine pH in patients with CaPHO4 stones who do not have distal RTA. A second aim was to identify patients in whom dietary factors do not seem to play a central role in the pathophysiology of their alkaline urine pH. Accordingly, the latter patients may have specific transport defects as a basis for their disease.

The label ‘incomplete RTA’ originated in an era where the lynchpin in the diagnosis of distal RTA was a high urine pH in patients with hyperchloraemic metabolic acidosis [8,9,10]. Hence, it is not surprising that when patients present with recurrent CaHPO4 stones accompanied by a high urine pH in the absence of hyperchloraemic metabolic acidosis, the term used to describe this clinical scenario was ‘incomplete RTA’. These same findings, however, are present in three different settings. The first subgroup of patients does not have a renal lesion—their high urine pH is the expected response to the intake of a high ‘alkaline-ash’ diet [7]. The second subgroup of patients has the subtype of distal RTA that is due to a decreased distal secretion of H+ [6] or augmented distal secretion of Formula [11], yet they do not have hyperchloraemic metabolic acidosis because it is masked by the intake of a diet that yields a low net H+ load. The diagnosis in these subgroups may be confirmed by the finding of a low rate of excretion of Formula . Patients with a low net distal H+ secretion will have a low rate of excretion of Formula in response to a chronic acid load (NH4Cl). Uniquely, those with the distal secretion of Formula subtype have been observed to have a high urine PCO2 in alkaline urine [11]. A third group of patients has what could be called ‘true incomplete RTA’, because they have a high urine pH and a high rate of NH4+ excretion (as compared with that of Formula ) [5]. The basis of their alkaline urine pH is an increased entry of NH3 into the lumen of the collecting duct; nevertheless, these patients represent a heterogeneous group with regard to the pathophysiology of this disorder. Since the rate of excretion of Formula in these patients is already high, a urine minus blood PCO2 test and an NH4Cl loading test are not needed to include a patient in this diagnostic category.

In summary, the term ‘incomplete RTA’ probably should be abandoned at this point in time (the Appendix). Alternatively, if one wished to use this term, it should be redefined—reserving it for one special subgroup of patients—those with persistently high urine pH values and a high rate of excretion of Formula as compared with that of Formula [6,12]. Of note, this later group, as described in this paper, has at least two pathophysiological reasons for their alkaline urine pH. It is for these reasons that we described our workup of patients with CaHPO4 stones using pathophysiological categories (e.g. high urine pH along with high rate of excretion of Formula ) to avoid misunderstandings due to terminology (Figure 1).

The key to our analysis of the basis of alkaline urine pH is an understanding of how acid balance and base balance are achieved [13,14]. Before discussing the data, we provide a brief synopsis of pertinent issues.

Acid-balance
Although the major acids requiring renal disposal are H2SO4 and phosphoric acid, only the H+ from H2SO4 require Formula excretion to eliminate these protons because of the low affinity of Formula for H+. Acid balance is normally achieved when Formula is excreted with an equivalent amount of Formula in the urine (Table 2) [15–17]. To examine the stimulus for the production of Formula in the proximal convoluted tubule (PCT), we measured the rate of citrate excretion as a ‘window’ on the PCT cell pH [18].

Base balance
Dietary alkali is derived from the metabolism of ingested fruits and vegetables, but it is not eliminated by the excretion of an appreciable quantity of Formula in the urine as the urine pH in our control subjects was consistently close to 6.0 (Figure 1). Therefore, dietary alkali is eliminated by excreting a family of organic anions, including citrate [14]. If there were a defect in the excretion of organic anions, excreting Formula may be the means to eliminate some of the dietary alkali, but this would raise the urine pH. Accordingly, we measured the rate of excretion of citrate to help evaluate the base balance [18]. We assessed net diet alkali using the calculation described in Subjects and methods.

On initial screening, 13/26 patients with a history of CaHPO4 stones were excluded because their urine pH was >6.5 for considerably less than 12/24 h. In 7/13 patients, the basis of a persistently high urine pH was a high addition of NH3 to the medullary collecting duct that was secondary to the renal response to a chronic dietary acid load (Figure 6). This subset was identified because they had high rates of excretion of Formula and Formula . The urine pH values in these patients, however, are rather higher than those observed in normal control subjects who were given a chronic acid load by ingesting NH4Cl. These subjects excreted large amounts of Formula at the time when the urine pH is ~6.0 [19–21]. Therefore, it is important to note that, while dietary factors seem to be important in the pathophysiology of their alkaline urine pH, it is also possible that a transport defect akin to the ones described below may also be present. To characterize the pathophysiology, these patients will need to be examined while consuming a standardized diet.


Figure 6
View larger version (15K):
[in this window]
[in a new window]
[Download PowerPoint slide]
 
Fig. 6. New insights into the physiology of renal transport of Figure 6. The medullary thick ascending limb (mTAL) of the loop of Henle is shown on the left and the medullary collecting duct (MCD) is shown on the right. The funnel-shaped structure in the MCD represents two different NH3 channels, one in the basolateral and the other in the luminal membrane. Reabsorption of Figure 6 from the mTAL and its diffusion to the MCD permits Figure 6 to enter the hydrophobic mouth of the NH3 channel where it is converted to H+ and NH3. This raises the local [NH3], which diffuses into the lumen of the MCD if this channel is open. This entry of NH3 raises the luminal pH despite continuing H+ secretion by the H+-ATPase. The net result is a higher urine pH and a somewhat higher rate of Figure 6 excretion.

 
In 4/13 patients, a contributing factor for their high urine pH seemed to be a large alkali intake. This was identified by finding an episodic diet net alkali load with a coincident rise in the urine pH and citrate excretion rate, as well as a fall in the rate of Formula excretion that was not due to a diminished rate of excretion of Formula (Figure 3).

In 2/13 patients, the pathophysiology of the alkaline urine pH did not seem to be related to dietary factors. In more detail, both had a rather high rate of excretion of Formula relative to their dietary acid load (rate of excretion of Formula ). These two patients were studied in more detail to identify possible transport defects. Of note, both patients had the onset of their stone disease at young age.

Possible basis for the high urine pH in the male patient
The male patient had marked hypocitraturia in the absence of systemic acidosis or hypokalaemia (Figure 5); this suggested that he might have intracellular acidosis restricted to PCT cells [4]. Accordingly, one explanation for his high urine pH might be the need to dispose of dietary alkali by excreting Formula instead of citrate because of enhanced proximal reabsorption of citrate [14]. The second reason for the high urine pH could be an increased medullary interstitial availability of NH3 caused by the high PCT [H+], which stimulated ammoniagenesis [22]. This will require, however, that gating of the NH3 channel be modulated by the availability of NH3 or a related compound or ion (Figure 6); this will be discussed in more detail when the data in the female patient are analysed.

Possible basis for the high urine pH in the female patient
The female patient, while similar in many respects, did not have a low rate of excretion of citrate (Figure 5). Therefore, it is unlikely that she had an acidified PCT cell pH. Newer insights into the physiology of the renal transport of Formula suggest a different possibility (Figure 6) [23]. There is an NH3 channel whose mouth is very hydrophobic, which allows for ~3 order of magnitude fall in the pK for Formula within the channel mouth [23]. This raises the concentration of NH3 within the channel by ~1000-fold, and provides the concentration difference needed for diffusion of NH3 into the lumen of the medullary collecting duct. Accelerated entry of NH3 into its lumen can raise both the UNH4 and the urine pH. There are two types of Rh-glycoproteins that may form these NH3 channels, one in the basolateral and the other in the luminal membrane of the medullary collecting duct cells in rat and mouse kidneys [24]. It is possible that a lesion that causes a higher open-probability and/or a greater number of NH3 channels enhances the entry of NH3 into the lumen of medullary collecting duct. This will drive the urine pH upward as well as increase the rate of excretion of Formula .



   Conclusions
 Top
 Abstract
 Introduction
 Subjects and methods
 Results
 Discussion
 Conclusions
 Appendix
 Acknowledgements
 References
 
Our data reveal that patients with CaHPO4 kidney stones are heterogeneous with respect to the pathophysiology of their alkaline urine pH. Two possible novel lesions that may cause persistently alkaline urine pH values in a subset of patients with CaHPO4 nephrolithiasis were described. Recognizing this difference in pathophysiology may lead to novel strategies for therapy.



   Appendix
 Top
 Abstract
 Introduction
 Subjects and methods
 Results
 Discussion
 Conclusions
 Appendix
 Acknowledgements
 References
 
Incomplete RTA
This diagnostic category is based on finding a persistently high urine pH in patients who do not have ‘complete’ distal RTA of the subtype with low net distal H+ secretion [5]—i.e. patients who do not have hyperchloraemic metabolic acidosis. Notwithstanding, it includes more than one specific disease or pathophysiological entity. Ruling out other causes of a high urine pH should improve diagnostic specificity.

Conditions to remove from the ‘incomplete RTA’ diagnostic category

(i) Patients with distal RTA due to low net distal secretion of H+ who consume a low net H+ load

Although these patients usually have a degree of acidaemia, a low blood pH may not be present if they ingest a low net H+ load. In more detail, if their diet were to have more alkali (e.g. fruit and vegetables) and/or less precursors of H2SO4 (e.g. low protein intake), acidaemia may be absent. Accordingly, the key to the diagnosis is a low rate of excretion of Formula (i.e., UNH4 < USO4 [6]) (equations A1 and A2). One would expect that these patients should develop acidaemia if they consume a typical Western diet. The diagnosis could be confirmed by finding of a low rate of excretion of Formula in response to a chronic acid (NH4Cl) load [25] and a low urine PCO2 in alkaline urine [26].

Formula 2(A1)

Formula 3(A2)

(ii) Large intake of alkali in a normal subject

A second category of patients who have a normal plasma pH and plasma Formula concentration along with a high urine pH includes normal individuals with a large dietary intake of alkali precursors. Clues to examine include the rate of excretion of Formula as compared with Formula excretion in mEq terms [6] (see equations A1 and A2) and the rate of excretion of net alkali [14] (e.g. organic anions including citrate). In more detail, shortly after dietary alkali is ingested, the rate of excretion of Formula as compared with Formula should fall while the rate of excretion of organic anions plus citrate should rise. To exclude these patients from the ‘true incomplete RTA’ category, they should be studied on a typical western diet to see if a high alkali ingestion may have been responsible for their high urine pH. Thus, this category resembles the patients with distal RTA due to low net H+ secretion and a low net H+ load described above, except that they will not develop acidaemia when they consume the typical Western diet.

Patients with true ‘incomplete RTA’
These patients also come to medical attention because they have CaHPO4 kidney stone disease. Their initial diagnostic workup also reveals a high urine pH for much of the day. The key diagnostic step in this group of patients is finding a high rate of excretion of Formula as compared with that of Formula (equations A1 and A2). Contrary to normal subjects in whom the daily excretion of Formula and Formula are in a 1 : 1 proportion and in the patients with distal RTA and a low net dietary intake of H+ precursors who excrete less Formula than Formula , their daily excretion of Formula is considerably greater than their daily excretion of Formula . Since the rate of excretion of Formula in these patients is already high relative to their dietary non-volatile acid load, an NH4Cl loading test is not required to confirm this diagnosis.

Since these patients achieve high rates of excretion of Formula while their urine pH is also high, the basis of their disease is a subgroup of disorders that have in common an increased entry of NH3 into the lumen of the collecting duct. We described two subtypes of ‘true incomplete RTA’ in the paper—those with an acidified proximal convoluted tubular cell pH and those with a primary increase in the medullary NH3 shunt [27].



   Acknowledgements
 Top
 Abstract
 Introduction
 Subjects and methods
 Results
 Discussion
 Conclusions
 Appendix
 Acknowledgements
 References
 
All sources of funding were from the Canadian Institutes of Health Research, Grant MT 15485. We are very grateful to Chee K. Chong, Stella Tang and S. Y. Lee for expert technical assistance.

Conflict of interest statement. None declared.



   References
 Top
 Abstract
 Introduction
 Subjects and methods
 Results
 Discussion
 Conclusions
 Appendix
 Acknowledgements
 References
 

  1. Coe FL and Parks JH. (2000) Pathogenesis and treatment of nephrolithiasis. In Seldin DW and Giebisch G (Eds.). The Kidney: Physiology & Pathophysiology(Lippincott Williams & Wilkins, Philadelphia PA) pp. 1841–1867.
  2. Evan AP, Lingeman JE, Coe FL, et al. (2005) Crystal-associated nephropathy in patients with brushite nephrolithiasis. Kidney Int 67:576–591.[CrossRef][Web of Science][Medline]
  3. Schwartz WB, Bank N, Cutler RWP. (1959) The influence of urinary ionic strength on phosphate pK2 and the determination of titratable acid. J Clin Invest 38:347–356.[Web of Science][Medline]
  4. Dedmond RE and Wrong O. (1962) The excretion of organic anion in renal tubular acidosis with particular reference to citrate. Clin Sci 22:19–32.[Web of Science][Medline]
  5. Kamel KS, Briceno LF, Santos MI, et al. (1997) A new classification for renal defects in net acid excretion. Am J Kidney Dis 29:126–136.
  6. Kamel KS, Cheema-Dhadli S, Halperin ML. (2002) Studies on the pathophysiology of the low urine pH in patients with uric acid stones. Kidney Int 61:988–994.[CrossRef][Web of Science][Medline]
  7. Kaitwatcharachai C, Vasuvattakul S, Yenchitsomanus P, et al. (1999) Distal renal tubular acidosis in a patient with southeast Asian ovalocytosis: possible interpretations of a high urine PCO2. Am J Kidney Dis 33:1147–1152.[Web of Science][Medline]
  8. Donnelly SM, Kamel KS, Vasuvattakul S, Narins RG, Halperin ML. (1992) Might distal renal tubular acidosis be a proximal disorder? Am J Kidney Dis 19:272–281.[Web of Science][Medline]
  9. Buckalew V Jr, McCurdy D, Ludwig G, Chaykin L, Elkinton J. (1968) Incomplete renal tubular acidosis: physiologic studies in three patients with a defect in lowering urine pH. Am J Med 45:32–42.[CrossRef][Web of Science][Medline]
  10. Tannen R, Falls W Jr, Brackett N Jr. (1975) Incomplete renal tubular acidosis: some clinical and physiological features. Nephron 15:111–123.[Web of Science][Medline]
  11. Oh MS and Carroll HJ. (1992) Whole body acid–base balance. Contrib Nephrol 100:89–104.[Medline]
  12. Wrong OM and Feest TG. (1980) The natural history of distal renal tubular acidosis. Contr Nephrol 21:137–144.
  13. Lin P, Cheema-Dhadli S, Chayaraks S, et al. (1998) Physiological role of the potential alkali load in the diet of the rat for acid–base balance. Am J Physiol 274:F1037–F1044.
  14. Cheema-Dhadli S, Lin S-H, Halperin ML. (2002) Mechanisms used to dispose of a progressively increasing alkali load in the rat. Am J Physiol 282:F1049–F1055.[Web of Science]
  15. Hunt J. (1956) The influence of dietary sulphur of the urinary output of acid in man. Clin Sci 15:119.[Medline]
  16. Relman AS, Lennon EJ, Lemann JJ. (1961) Endogenous production of fixed acid and the measurement of the net balance of acid in normal subjects. J Clin Invest 40:1621–1630.[Web of Science][Medline]
  17. Halperin ML and Jungas RL. (1983) Metabolic production and renal disposal of hydrogen ions. Kidney Int 24:709–713.[Web of Science][Medline]
  18. Simpson D. (1983) Citrate excretion: a window on renal metabolism. Am J Physiol 244:F223–F234.
  19. Madison LL and Seldin DW. (1958) Ammonia excretion and renal enzymatic adaptation in human subjects, as disclosed by administration of precursor amino acids. J Clin Invest 37:1615–1627.[Web of Science][Medline]
  20. Simpson D. (1971) Control of hydrogen ion homeostasis and renal acidosis. Medicine 50:503–541.[CrossRef][Medline]
  21. Kamel KS, Lin S-H, Cheema-Dhadli S, Marliss EB, Halperin ML. (1998) Prolonged total fasting: a feast for the integrative physiologist. Kidney Int 53:531–539.[CrossRef][Web of Science][Medline]
  22. Nagami GT. (2000) Renal ammonia production and excretion. In Seldin DW and Giebisch G (Eds.). The Kidney: Physiology & Pathophysiology.(Lippincott Williams & Wilkins, Philadelphia, PA) pp. 1995–2014.
  23. Khademii S, O’Connell J III, Remis J, et al. (2004) Mechanism of ammonia transport by AMT/MEP/Rh: structure of AMTB at 135A. Science 305:1587–1594.[Abstract/Free Full Text]
  24. Weiner D. (2004) The Rh gene family and ammonium transport. Curr Opin Nephrol Hy 13:533–540.[Web of Science][Medline]
  25. Wrong O and Davies W. (1959) The excretion of acid in renal disease. Quart J Med 23:259–313.
  26. Halperin ML, Goldstein MB, Haig A, Johnson MD, Stinebaugh BJ. (1974) Studies on the pathogenesis of type I (distal) renal tubular acidosis as revealed by the urinary PCO2 tensions. J Clin Invest 53:669–677.[Web of Science][Medline]
  27. Knepper MA, Packer R, Good DW. (1989) Ammonium transport in the kidney. Physiol Rev 69:179–249.[Free Full Text]
Received for publication: 6. 3.06
Accepted in revised form: 18. 8.06


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?



This Article
Right arrow Abstract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
22/2/424    most recent
gfl588v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Kamel, K. S.
Right arrow Articles by Halperin, M. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kamel, K. S.
Right arrow Articles by Halperin, M. L.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?